Encompass Health Corporation (EHC) 2024年年度报告「NYSE」.pdf

1、2024 ANNUAL REPORTEncompass Health CorporationWho we are#1Owner and operator of inpatient rehabilitation hospitals in terms of patients treated,revenues and number of hospitalsNumber of states in which we operate38and Puerto Rico 166Inpatient rehabilitation hospitals2025Fortune Worlds Most Admired C

2、ompaniesForbes Most Trusted Companies in America 2024Beckers Top Places to Work in Healthcare 2025 Fortune Media IP Limited.All rights reserved.Fortune is a registered trademark and Fortune Worlds Most Admired Companies is trademark of Fortune Media IP Limited and are used under license.Fortune and

3、Fortune Media IP Limited are not affiliated with,and do not endorse products or services of,Encompass Health.2024 Forbes Media LLC.All rights reserved.Used under license.We are well positioned for future growth Strong financial performanceDisclosures,including reconciliations to the most comparable

4、GAAP financial measure,for non-GAAP financial information can be found in Appendix A to the Proxy Statement herein and at the end of the letter from the Chairman and CEO in this Annual Report.6 to 10 de novos per year80 to 120 bed additions per year6%to 8%discharge CAGR2023-2027 GROWTH TARGETS$5,373

5、.2 million in net operating revenue up 11.9%from 2023$1,103.7million in adjusted EBITDA up 13.7%from 2023$690.3million in adjusted free cash flow-up 31.3%from 20232.2x net leverage ratio,down from 2.7x in 2023FINANCIAL HIGHLIGHTS 2024Capacity expansion Opened 6 de novo hospitals,adding 280 beds Open

6、ed a 40-bed satellite hospital Added 107 beds to existing hospitals A total of 427 beds added to IRF capacity across 13 statesTotal discharge growth Total discharge growth of 8.3%with 5.6%same store growth Treated approximately 7%of patients recovering from a stroke in the United StatesAdvanced tech